Skip to main content
Fig. 1 | Trials

Fig. 1

From: Comparative study of the effect of neuromuscular electrical stimulation and oral administration of branched-chain amino acid on preventing sarcopenia in patients after living-donor liver transplantation: study protocol for an open-label randomized controlled trial

Fig. 1

Study design. An eligibility check is conducted, and the patient’s informed consent is obtained at visit 1. The patients who satisfy the inclusion criteria are enrolled in the study at visit 2; they are randomized in a 1:1 ratio to the NMES and BCAA group (administered Aminoleban EN 100 mg) and the control group. BCAA, branched-chain amino acids; LDLT, living donor liver transplantation; NMES, .neuromuscular electrical stimulation

Back to article page

Trials

ISSN: 1745-6215